T. Rowe Price Associates »

Trisalus Life Sciences shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $86k 21k 4.04
2025-12-31 $104k 15k 7.02

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Trisalus Life Sciences

First Light Asset Management
BlackRock
Vanguard Capital Management
HPM Partners
Geode Capital Management
Nantahala Capital Management
Gilder, Gagnon, Howe & Co
White Pine Capital
Thompson, Siegel, & Walmsley
Kennedy Capital Management
Morgan Stanley
Northern Trust
Vanguard Portfolio Management
State Street Corporation
Vanguard Fiduciary Trust

View all funds holding Trisalus Life Sciences